2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary
Jennifer S. Lawton, Brittany A. Zwischenberger, Frank W. Sellke(Brown University), Roxana Mehran(Mount Sinai Hospital), Michael C. Grant(Johns Hopkins University), Paul Kurlansky, James M. Bischoff, Creighton W. Don(University of Washington), Theresa M. Beckie, Celina M. Yong(VA Palo Alto Health Care System), Zachary D. Goldberger, Jang B. Jaswal, Sripal Bangalore(New York University), Thomas S. Metkus(Johns Hopkins University), J. Michael DiMaio(Baylor Medical Center at Garland), John A. Bittl(Brigham and Women's Hospital), Stephen E. Fremes(Institute of Health Services and Policy Research), Garima Sharma(Guru Nanak Dev University), Mario F. Gaudino, Lorraine C. Nnacheta(American Academy of Otolaryngology — Head and Neck Surgery), Jacqueline E. Tamis-Holland, Mauricio G. Cohen(Santa Ana College), Sunil V. Rao, Eric Bates(Apple (Israel))
Cited by 364
Related Papers
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Circulation|2011|3.3k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2011|2.2k